Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Early research (Phase 1)Study completedNCT03018223What this trial is testingCalcineurin Inhibitor-Free GVHD Prevention Regimen After Related Haplo PBSCTWho this might be right forNon-Hodgkin's LymphomaAcute Leukemia in RemissionChronic Myeloid Leukemia+5 more H. Lee Moffitt Cancer Center and Research Institute 32
Testing effectiveness (Phase 2)Ended earlyNCT02147873What this trial is testingStudy of Azacitidine With or Without Birinapant in Subjects With MDS or CMMoLWho this might be right forMyelodysplastic Syndrome (MDS)Chronic Myelomonocytic Leukemia (CMML) TetraLogic Pharmaceuticals 118
Testing effectiveness (Phase 2)UnknownNCT00885508What this trial is testingThe Efficacy and Safety of Lenalidomide Combined to Escalating Doses of Chemotherapy in Intermediate-2-or High Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) With Del 5qWho this might be right forMyelodysplastic SyndromeChronic Myelomonocytic LeukemiaAcute Myeloid Leukemia Groupe Francophone des Myelodysplasies 85
Early research (Phase 1)Study completedNCT00588991What this trial is testingVeliparib and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leukemia, High-Risk Myelodysplasia, or Aggressive Myeloproliferative DisordersWho this might be right forAdult Acute Megakaryoblastic LeukemiaAdult Acute Monoblastic LeukemiaAdult Acute Monocytic Leukemia+20 more National Cancer Institute (NCI) 12
Testing effectiveness (Phase 2)Study completedNCT01823198What this trial is testingDonor Natural Killer Cells and Donor Stem Cell Transplant in Treating Patients With High Risk Myeloid MalignanciesWho this might be right forAccelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Erythroid LeukemiaAcute Megakaryoblastic Leukemia+12 more M.D. Anderson Cancer Center 63
Testing effectiveness (Phase 2)WithdrawnNCT06597734What this trial is testingStudy Evaluating Olutasidenib in Combination With Hypomethylating Agents in Patients With IDH1-mutated Higher-risk Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Advanced Myeloproliferative NeoplasmWho this might be right forChronic Myelomonocytic LeukemiaAdvanced Myeloproliferative NeoplasmsIDH1-mutated Higher-Risk Myelodysplastic Syndromes M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT02610777What this trial is testingAn Efficacy and Safety Study of Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine in Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML) and Low-Blast Acute Myelogenous Leukemia (AML)Who this might be right forMyelodysplastic SyndromesLeukemia, Myelomonocytic, ChronicLeukemia, Myeloid, Acute Millennium Pharmaceuticals, Inc. 120
Testing effectiveness (Phase 2)Looking for participantsNCT06523556What this trial is testingAxatilimab With or Without Azacitidine for the Treatment of Patients With Advanced Phase Myeloproliferative Neoplasms, Myeloproliferative Neoplasm/Myelodysplastic Syndrome Overlap or High Risk Chronic Myelomonocytic LeukemiaWho this might be right forAtypical Chronic Myeloid LeukemiaChronic Myelomonocytic LeukemiaMyelodysplastic/Myeloproliferative Neoplasm+5 more Uma Borate 49
Testing effectiveness (Phase 2)Active Not RecruitingNCT05768711What this trial is testingAzacitidine Combined With Venetoclax in Patients With Higher-risk Chronic Myelomonocytic Leukemia (AVENHIR)Who this might be right forChronic Myeloid Leukemia Groupe Francophone des Myelodysplasies 44
Early research (Phase 1)Study completedNCT00301938What this trial is testing7-Hydroxystaurosporine and Perifosine in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia or High Risk Myelodysplastic SyndromesWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)+23 more National Cancer Institute (NCI) 30
Early research (Phase 1)Study completedNCT00002588What this trial is testingCombination Chemotherapy in Treating Patients With Recurrent or Refractory LeukemiaWho this might be right forLeukemia Case Comprehensive Cancer Center 30
Testing effectiveness (Phase 2)Ended earlyNCT04550442What this trial is testingVenetoclax and Azacitidine for the Treatment of Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Chronic Myelomonocytic LeukemiaWho this might be right forRecurrent Chronic Myelomonocytic LeukemiaRecurrent Myelodysplastic SyndromeRefractory Chronic Myelomonocytic Leukemia+2 more M.D. Anderson Cancer Center 34
Not applicableStudy completedNCT00296023What this trial is testingDonor Stem Cell Transplant in Treating Older or Frail Patients With Hematologic CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+2 more University of California, San Francisco 25
Large-scale testing (Phase 3)Looking for participantsNCT04708054What this trial is testingVenetoclax to Improve Outcomes of Fractionated Busulfan Regimen in Patients With High-Risk AML and MDSWho this might be right forAcute Myeloid LeukemiaChronic Myelomonocytic LeukemiaMyelodysplastic Syndrome M.D. Anderson Cancer Center 324
Large-scale testing (Phase 3)Active Not RecruitingNCT05883956What this trial is testingA Study Comparing Treatment Preference Between Oral Decitabine/Cedazuridine and Azacitidine in Myelodysplastic Syndrome, Low-Blast Acute Myeloid Leukemia, or Chronic Myelomonocytic LeukemiaWho this might be right forMyelodysplastic SyndromesLeukemia, Myeloid, AcuteLeukemia, Myelomonocytic, Chronic+1 more Otsuka Australia Pharmaceutical Pty Ltd 13
Testing effectiveness (Phase 2)Study completedNCT00014469What this trial is testingCombination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Advanced Hematologic CancerWho this might be right forGraft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes+1 more Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00002800What this trial is testingChemotherapy in Treating Patients With Newly Diagnosed Acute or Chronic Myelogenous Leukemia or Myelodysplastic SyndromeWho this might be right forLeukemiaMyelodysplastic SyndromesNeutropenia Memorial Sloan Kettering Cancer Center 60
Early research (Phase 1)Study completedNCT01757639What this trial is testingIpilimumab in Treating Patients With Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeChronic Myelomonocytic LeukemiaMyelodysplastic Syndrome+3 more National Cancer Institute (NCI) 42
Early research (Phase 1)Study completedNCT01254578What this trial is testingLenalidomide After Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic CancersWho this might be right forAdult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11+39 more National Cancer Institute (NCI) 17